Ultrasound-Mediated Drug Delivery: Range of Ultrasonic Interactions and Applications in Biological Systems

IEEE Engineering in Medicine and Biology

Volumn 28, Issue 1, 2009, Pages 64-75

  Pua, Eric C ^a   Zhong, Pei ^a  

^a Duke University   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANIMAL; BLOOD BRAIN BARRIER; CELL MEMBRANE; CELL STRAIN HL 60; DRUG DELIVERY SYSTEM; FIBRINOLYTIC THERAPY; GENE THERAPY; GENETIC TRANSFECTION; HUMAN; METHODOLOGY; REVIEW; ULTRASOUND; ULTRASTRUCTURE;

ANIMALS; BLOOD-BRAIN BARRIER; CELL MEMBRANE; DRUG DELIVERY SYSTEMS; GENE THERAPY; HL-60 CELLS; HUMANS; THROMBOLYTIC THERAPY; TRANSFECTION; ULTRASONICS;

EID: 64749089034     PISSN: 07395175     EISSN: None     Source Type: Journal    
DOI: 10.1109/MEMB.2008.931017     Document Type: Article

References (141)

1. E. D. Light, S. Mukundan, P. D. Wolf, and S. W. Smith, “Real-time 3-D intracranial ultrasound with an endoscopic matrix array transducer,” Ultrasound Med. Biol., vol. 33, pp. 1277–1284, Aug. 2007.
2. K. Nightingale, M. Palmeri, L. Zhai, K. Frinkley, M. Wang, J. Dahl, B. Fahey, S. Hsu, D. Bradway, and G. Trahey, “Impulsive acoustic radiation force: Imaging approaches and clinical applications,” J. Acoust. Soc. Am., vol. 123, p. 3792, May 2008.
3. M. R. Bailey, V. A. Khokhlova, O. A. Sapozhnikov, S. G. Kargl, and L. A. Crum, “Physical mechanisms of the therapeutic effect of ultrasound—A review,” Acoust. Phys., vol. 49, pp. 369–388, Aug. 2003.
4. T. Watson, “Ultrasound in contemporary physiotherapy practice,” Ultrasonics, vol. 48, no. 4, pp. 321–329, Mar. 2008.
5. C. J. Diederich and K. Hynynen, “Ultrasound technology for hyperthermia,” Ultrasound Med Biol., vol. 25, pp. 871–887, July 1999.
6. J. E. Kennedy, G. R. Ter Haar, and D. Cranston, “High intensity focused ultrasound: Surgery of the future?” Br. J. Radiol., vol. 76, pp. 590–599, Sept. 2003.
7. G. ter Haar, “Ultrasound focal beam surgery,” Ultrasound Med. Biol., vol. 21, no. 9, pp. 1089–1100, 1995.
8. F. Wu, Z. B. Wang, W. Z. Chen, J. Z. Zou, J. Bai, H. Zhu, K. Q. Li, F. L. Xie, C. B. Jin, H. B. Su, and G. W. Gao, “Extracorporeal focused ultrasound surgery for treatment of human solid carcinomas: Early Chinese clinical experience,” Ultrasound Med. Biol., vol. 30, pp. 245–260, Feb. 2004.
9. M. O. Koch, T. Gardner, L. Cheng, R. J. Fedewa, R. Seip, and N. T. Sanghvi, “Phase I/II trial of high intensity focused ultrasound for the treatment of previously untreated localized prostate cancer,” J. Urol., vol. 178, no. 6, pp. 2366–2370, Dec. 2007; discussion 2370–2371.
10. J. Kost, “Ultrasound-assisted insulin delivery and noninvasive glucose sensing,” Diabetes Technol Ther., vol. 4, no. 4, pp. 489–497, 2002.
11. V. Zderic, J. I. Clark, and S. Vaezy, “Drug delivery into the eye with the use of ultrasound,” J. Ultrasound Med., vol. 23, no. 10, pp. 1349–1359, Oct. 2004.
12. M. Kinoshita, N. McDannold, F. A. Jolesz, and K. Hynynen, “Noninvasive localized delivery of Herceptin to the mouse brain by MRI-guided focused ultrasound-induced blood-brain barrier disruption,” Proc. Natl. Acad. Sci. USA., vol. 103, no. 31, pp. 11719–11723, Aug. 2006.
13. F. Y. Yang, W. M. Fu, R. S. Yang, H. C. Liou, K. H. Kang, and W. L. Lin, “Quantitative evaluation of focused ultrasound with a contrast agent on blood-brain barrier disruption,” Ultrasound Med. Biol., vol. 33, no. 9, pp. 1421–1427, Sept. 2007.
14. S. Bao, B. D. Thrall, and D. L. Miller, “Transfection of a reporter plasmid into cultured cells by sonoporation in vitro,” Ultrasound Med. Biol., vol. 23, no. 6, pp. 953–959, 1997.
15. Y. Taniyama, K. Tachibana, K. Hiraoka, M. Aoki, S. Yamamoto, K. Matsumoto, T. Nakamura, T. Ogihara, Y. Kaneda, and R. Morishita, “Development of safe and efficient novel nonviral gene transfer using ultrasound: Enhancement of transfection efficiency of naked plasmid DNA in skeletal muscle,” Gene Ther., vol. 9, no. 6, pp. 372–380, Mar. 2002.
16. I. Rosenthal, J. Z. Sostaric, and P. Riesz, “Sonodynamic therapy—A review of the synergistic effects of drugs and ultrasound,” Ultrason. Sonochem., vol. 11, no. 6, pp. 349–363, Sept. 2004.
17. R. E. Apfel, “Acoustic cavitation: A possible consequence of biomedical uses of ultrasound,” Br. J. Cancer, vol. 5, pp. 140–146, Mar. 1982.
18. E. B. Flint and K. S. Suslick, “The temperature of cavitation,” Science, vol. 253, no. 5026, pp. 1397–1399, Sept. 1991.
19. T. Kondo and E. Kano, “Effect of free radicals induced by ultrasonic cavitation on cell killing,” Int. J. Radiat. Biol., vol. 54, no. 3, pp. 475–486, Sept. 1988.
20. I. Lavon and J. Kost, “Ultrasound and transdermal drug delivery,” Drug Discov. Today, vol. 9, pp. 670–676, Aug. 2004.
21. A. Boucaud, “Trends in the use of ultrasound-mediated transdermal drug delivery,” Drug Discov. Today, vol. 9, no. 19, pp. 827–828, Oct. 2004.
22. S. Mitragotri, D. Blankschtein, and R. Langer, “Ultrasound-mediated trans-dermal protein delivery,” Science, vol. 269, no. 5225, pp. 850–853, Aug. 1995.
23. M. Kuroki, K. Hachimine, H. Abe, H. Shibaguchi, M. Kuroki, S. Maekawa, J. Yanagisawa, T. Kinugasa, T. Tanaka, and Y. Yamashita, “Sonodynamic therapy of cancer using novel sonosensitizers,” Anticancer Res., vol. 27, no. 6, pp. 3673–3677, Dec. 2007.
24. M. W. Miller, D. L. Miller, and A. A. Brayman, “A review of in vitro bioef-fects of inertial ultrasonic cavitation from a mechanistic perspective,” Ultrasound Med. Biol., vol. 22, no. 9, pp. 1131–1154, 1996.
25. K. Ferrara, R. Pollard, and M. Borden, “Ultrasound microbubble contrast agents: Fundamentals and application to gene and drug delivery,” Annu. Rev. Biomed. Eng., vol. 9, pp. 415–447, 2007.
26. Y. Liu, H. Miyoshi, and M. Nakamura, “Encapsulated ultrasound microbub-bles: Therapeutic application in drug/gene delivery,” J. Contr. Release, vol. 114, no. 1, pp. 89–99, Aug. 2006.
27. S. Mitragotri, “Healing sound: The use of ultrasound in drug delivery and other therapeutic applications,” Nat. Rev., vol. 4, no. 3, pp. 255–260, Mar. 2005.
28. J. L. Bull, “The application of microbubbles for targeted drug delivery,” Expert Opin. Drug Deliv., vol. 4, no. 5, pp. 475–493, Sept. 2007.
29. S. Paliwal and S. Mitragotri, “Ultrasound-induced cavitation: Applications in drug and gene delivery,” Expert Opin Drug Deliv., vol. 3, no. 6, pp. 713–726, Nov. 2006.
30. M. Postema and O. H. Gilja, “Ultrasound-directed drug delivery,” Curr. Pharm. Biotechnol., vol. 8, no. 6, pp. 355–361, Dec. 2007.
31. W. G. Pitt and G. A. Husseini, “Ultrasound in drug and gene delivery,” Adv. Drug Deliv. Rev., vol. 60, pp. 1095–1096, June 2008.
32. K. W. Ferrara, “Driving delivery vehicles with ultrasound,” Adv. Drug Deliv. Rev., vol. 60, pp. 1097–1102, June 2008.
33. M. Fechheimer, J. F. Boylan, S. Parker, J. E. Sisken, G. L. Patel, and S. G. Zimmer, “Transfection of mammalian cells with plasmid DNA by scrape loading and sonication loading,” Proc. Natl. Acad. Sci. USA., vol. 84, pp. 8463–8467, Dec. 1987.
34. M. Fechheimer, C. Denny, R. F. Murphy, and D. L. Taylor, “Measurement of cytoplasmic pH in Dictyostelium discoideum by using a new method for introducing macromolecules into living cells,” Eur. J. Cell Biol., vol. 40, pp. 242–247, Apr. 1986.
35. K. Fellinger and J. Schmidt, Klinik and Therapies des Chromischen Gelenk-reumatismus. Vienna, Austria: Maudrich, 1954.
36. M. Joersbo and J. Brunstedt, “Sonication—A new method for gene-transfer to plants,” Physiol Plantarum, vol. 85, pp. 230–234, June 1992.
37. M. A. Dinno, L. A. Crum, and J. Wu, “The effect of therapeutic ultrasound on electrophysiological parameters of frog skin,” Ultrasound Med. Biol., vol. 15, no. 5, pp. 461–470, 1989.
38. M. A. Dinno, M. Dyson, S. R. Young, A. J. Mortimer, J. Hart, and L. A. Crum, “The significance of membrane changes in the safe and effective use of therapeutic and diagnostic ultrasound,” Phys. Med. Biol., vol. 34, pp. 1543–1552, Nov. 1989.
39. M. Fahnestock, V. G. Rimer, R. M. Yamawaki, P. Ross, and P. D. Edmonds, “Effects of ultrasound exposure in vitro on neuroblastoma cell membranes,” Ultrasound Med. Biol., vol. 15, no. 2, pp. 133–144, 1989.
40. A. J. Mortimer and M. Dyson, “The effect of therapeutic ultrasound on calcium uptake in fibroblasts,” Ultrasound Med. Biol., vol. 14, no. 6, pp. 499–506, 1988.
41. M. Delius and G. Adams, “Shock wave permeabilization with ribosome inactivating proteins: A new approach to tumor therapy,” Cancer Res., vol. 59, pp. 5227–5232, Oct. 1999.
42. S. Gambihler, M. Delius, and J. W. Ellwart, “Permeabilization of the plasma membrane of L1210 mouse leukemia cells using lithotripter shock waves,” J. Membr. Biol., vol. 141, pp. 267–275, Sept. 1994.
43. D. L. Miller, A. R. Williams, J. E. Morris, and W. B. Chrisler, “Sonoporation of erythrocytes by lithotripter shockwaves in vitro,” Ultrasonics, vol. 36, pp. 947–952, Aug. 1998.
44. P. Zhong, H. Lin, X. Xi, S. Zhu, and E. S. Bhogte, “Shock wave-inertial microbubble interaction: Methodology, physical characterization, and bioeffect study,” J. Acoust. Soc. Am., vol. 105, pp. 1997–2009, Mar. 1999.
45. R. P. Holmes, L. D. Yeaman, R. G. Taylor, and D. L. McCullough, “Altered neutrophil permeability following shock wave exposure in vitro,” J. Urol., vol. 147, pp. 733–737, Mar. 1992.
46. M. Delius, “Minimal static excess pressure minimises the effect of extracorporeal shock waves on cells and reduces it on gallstones,” Ultrasound Med. Biol., vol. 23, no. 4, pp. 611–617, 1997.
47. H. J. Kim, J. F. Greenleaf, R. R. Kinnick, J. T. Bronk, and M. E. Bolander, “Ultrasound-mediated transfection of mammalian cells,” Hum. Gene Ther., vol. 7, pp. 1339–1346, July 1996.
48. J. C. Cusack, Jr. and K. K. Tanabe, “Introduction to cancer gene therapy,” Surg. Oncol. Clin. North Am., vol. 11, pp. 497–519, July 2002.
49. A. Fischer, S. Hacein-Bey, and M. Cavazzana-Calvo, “Gene therapy of severe combined immunodeficiencies,” Nat. Rev., vol. 2, pp. 615–621, Aug. 2002.
50. D. J. Rader, “Gene therapy for atherosclerosis,” Int. J. Clin. Lab. Res., vol. 27, no. 1, pp. 35–43, 1997.
51. B. D. Brown and D. Lillicrap, “Dangerous liaisons: The role of “danger” signals in the immune response to gene therapy,” Blood, vol. 100, pp. 1133–1140, Aug. 2002.
52. E. Check, “Cancer fears cast doubts on future of gene therapy,” Nature, vol. 421, p. 678, Feb. 2003.
53. S. Hacein-Bey-Abina, C. von Kalle, M. Schmidt, F. Le Deist, N. Wulffraat, E. McIntyre, I. Radford, J. L. Villeval, C. C. Fraser, M. Cavazzana-Calvo, and A. Fischer, “A serious adverse event after successful gene therapy for X-linked severe combined immunodeficiency,” N. Engl. J. Med., vol. 348, pp. 255–256, Jan. 2003.
54. N. R. Hackett, S. M. Kaminsky, D. Sondhi, and R. G. Crystal, “Antivector and antitransgene host responses in gene therapy,” Curr. Opin. Mol. Ther., vol. 2, pp. 376–382, Aug. 2000.
55. D. B. Tata, F. Dunn, and D. J. Tindall, “Selective clinical ultrasound signals mediate differential gene transfer and expression in two human prostate cancer cell lines: LnCap and PC-3,” Biochem Biophys. Res. Commun., vol. 234, pp. 64–67, May 1997.
56. A. Lawrie, A. F. Brisken, S. E. Francis, D. I. Tayler, J. Chamberlain, D. C. Crossman, D. C. Cumberland, and C. M. Newman, “Ultrasound enhances reporter gene expression after transfection of vascular cells in vitro,” Circulation, vol. 99, pp. 2617–2620, May 1999.
57. J. L. Cohen, J. Cheirif, D. S. Segar, L. D. Gillam, J. S. Gottdiener, E. Hausnerova, and D. E. Bruns, “Improved left ventricular endocardial border delineation and opacification with OPTISON (FS069), a new echocardiographic contrast agent. Results of a phase III multicenter trial,” J. Am. Coll. Cardiol., vol. 32, pp. 746–752, Sept. 1998.
58. L. J. Crouse, J. Cheirif, D. E. Hanly, J. A. Kisslo, A. J. Labovitz, J. S. Raichlen, R. W. Schutz, P. M. Shah, and M. D. Smith, “Opacification and border delineation improvement in patients with suboptimal endocardial border definition in routine echocardiography: Results of the Phase III Albunex multicenter trial,” J. Am. Coll. Cardiol., vol. 22, pp. 1494–1500, Nov. 1993.
59. W. J. Greenleaf, M. E. Bolander, G. Sarkar, M. B. Goldring, and J. F. Greenleaf, “Artificial cavitation nuclei significantly enhance acoustically induced cell transfection,” Ultrasound Med. Biol., vol. 24, pp. 587–595, May 1998.
60. M. Ward, J. Wu, and J. F. Chiu, “Ultrasound-induced cell lysis and sonopo-ration enhanced by contrast agents,” J. Acoust. Soc. Am., vol. 105, pp. 2951–2957, May 1999.
61. P. E. Huber and P. Pfisterer, “In vitro and in vivo transfection of plasmid DNA in the Dunning prostate tumor R3327-AT1 is enhanced by focused ultrasound,” Gene Ther., vol. 7, pp. 1516–1525, Sept. 2000.
62. R. Ogawa, T. Kondo, H. Honda, Q. L. Zhao, S. Fukuda, and P. Riesz, “Effects of dissolved gases and an echo contrast agent on ultrasound mediated in vitro gene transfection,” Ultrason. Sonochem., vol. 9, pp. 197–203, Sept. 2002.
63. H. R. Guzman, D. X. Nguyen, S. Khan, and M. R. Prausnitz, “Ultrasound-mediated disruption of cell membranes. I. Quantification of molecular uptake and cell viability,” J. Acoust. Soc. Am., vol. 110, pp. 588–596, July 2001.
64. M. Duvshani-Eshet and M. Machluf, “Therapeutic ultrasound optimization for gene delivery: A key factor achieving nuclear DNA localization,” J. Contr. Release, vol. 108, pp. 513–528, Nov. 2005.
65. L. B. Feril, Jr., R. Ogawa, K. Tachibana, and T. Kondo, “Optimized ultra-sound-mediated gene transfection in cancer cells,” Cancer Sci., vol. 97, pp. 1111–1114, Oct. 2006.
66. H. Hosseinkhani, T. Aoyama, O. Ogawa, and Y. Tabata, “Ultrasound enhancement of in vitro transfection of plasmid DNA by a cationized gelatin,” J. Drug Target., vol. 10, pp. 193–204, May 2002.
67. H. D. Liang, Q. L. Lu, S. A. Xue, M. Halliwell, T. Kodama, D. O. Cosgrove, H. J. Stauss, T. A. Partridge, and M. J. Blomley, “Optimisation of ultrasound-mediated gene transfer (sonoporation) in skeletal muscle cells,” Ultrasound Med. Biol., vol. 30, pp. 1523–1529, Nov. 2004.
68. Y. Z. Zhao, Y. K. Luo, H. D. Liang, X. G. Mei, J. Tang, C. T. Lu, Y. Zhang, and Q. Lin, “Comparing transfection efficiency and safety for antisense oligo-deoxyribonucleotide between phospholipids-based microbubbles and liposomes,” J. Drug Target., vol. 14, pp. 687–693, Dec. 2006.
69. M. Kinoshita and K. Hynynen, “A novel method for the intracellular delivery of siRNA using microbubble-enhanced focused ultrasound,” Biochem. Biophys. Res. Commun., vol. 335, pp. 393–399, Sept. 2005.
70. W. S. Chen, X. Lu, Y. Liu, and P. Zhong, “The effect of surface agitation on ultrasound-mediated gene transfer in vitro,” J. Acoust. Soc. Am., vol. 116, pp. 2440–2450, Oct. 2004.
71. D. L. Miller and J. Quddus, “Sonoporation of monolayer cells by diagnostic ultrasound activation of contrast-agent gas bodies,” Ultrasound Med. Biol., vol. 26, pp. 661–667, May 2000.
72. A. A. Rahim, S. L. Taylor, N. L. Bush, G. R. ter Haar, J. C. Bamber, and C. D. Porter, “Spatial and acoustic pressure dependence of microbubble-mediated gene delivery targeted using focused ultrasound,” J. Gene Med., vol. 8, pp. 1347–1357, Nov. 2006.
73. V. G. Zarnitsyn and M. R. Prausnitz, “Physical parameters influencing optimization of ultrasound-mediated DNA transfection,” Ultrasound Med. Biol., vol. 30, pp. 527–538, Apr. 2004.
74. D. Sheyn, N. Kimelman-Bleich, G. Pelled, Y. Zilberman, D. Gazit, and Z. Gazit, “Ultrasound-based nonviral gene delivery induces bone formation in vivo,” Gene Ther., vol. 15, pp. 257–266, Feb. 2008.
75. Q. L. Lu, H. D. Liang, T. Partridge, and M. J. Blomley, “Microbubble ultrasound improves the efficiency of gene transduction in skeletal muscle in vivo with reduced tissue damage,” Gene Ther., vol. 10, pp. 396–405, Mar. 2003.
76. M. Saito, O. Mazda, K. A. Takahashi, Y. Arai, T. Kishida, M. Shin-Ya, A. Inoue, H. Tonomura, K. Sakao, T. Morihara, J. Imanishi, M. Kawata, and T. Kubo, “Sonoporation mediated transduction of pDNA/siRNA into joint syno-vium in vivo,” J. Orthop. Res., vol. 25, pp. 1308–1316, Oct. 2007.
77. Y. Yamashita, M. Shimada, K. Tachibana, N. Harimoto, E. Tsujita, K. Shirabe, J. Miyazaki, and K. Sugimachi, “In vivo gene transfer into muscle via electro-sonoporation,” Hum. Gene Ther., vol. 13, pp. 2079–2084, Nov. 2002.
78. D. Mukherjee, J. Wong, B. Griffin, S. G. Ellis, T. Porter, S. Sen, and J. D. Thomas, “Ten-fold augmentation of endothelial uptake of vascular endothelial growth factor with ultrasound after systemic administration,” J. Am. Coll. Cardiol., vol. 35, pp. 1678–1686, May 2000.
79. M. Shimamura, N. Sato, Y. Taniyama, S. Yamamoto, M. Endoh, H. Kurinami, M. Aoki, T. Ogihara, Y. Kaneda, and R. Morishita, “Development of efficient plasmid DNA transfer into adult rat central nervous system using microbubble-enhanced ultrasound,” Gene Ther., vol. 11, pp. 1532–1539, Oct. 2004.
80. C. H. Miao, A. A. Brayman, K. R. Loeb, P. Ye, L. Zhou, P. Mourad, and L. A. Crum, “Ultrasound enhances gene delivery of human factor IX plasmid,” Hum. Gene Ther., vol. 16, pp. 893–905, July 2005.
81. P. E. Huber, M. J. Mann, L. G. Melo, A. Ehsan, D. Kong, L. Zhang, M. Rezvani, P. Peschke, F. Jolesz, V. J. Dzau, and K. Hynynen, “Focused ultrasound (HIFU) induces localized enhancement of reporter gene expression in rabbit carotid artery,” Gene Ther., vol. 10, pp. 1600–1607, Sept. 2003.
82. S. Xenariou, U. Griesenbach, H. D. Liang, J. Zhu, R. Farley, L. Somerton, C. Singh, P. K. Jeffery, S. Ferrari, R. K. Scheule, S. H. Cheng, D. M. Geddes, M. Blomley, and E. W. Alton, “Use of ultrasound to enhance nonviral lung gene transfer in vivo,” Gene Ther., vol. 14, pp. 768–774, May 2007.
83. C. Y. Lai, C. H. Wu, C. C. Chen, and P. C. Li, “Quantitative relations of acoustic inertial cavitation with sonoporation and cell viability,” Ultrasound Med Biol., vol. 32, pp. 1931–1941, Dec. 2006.
84. D. M. Hallow, A. D. Mahajan, T. E. McCutchen, and M. R. Prausnitz, “Measurement and correlation of acoustic cavitation with cellular bioeffects,” Ultrasound Med. Biol., vol. 32, pp. 1111–1122, July 2006.
85. C. X. Deng, F. Sieling, H. Pan, and J. Cui, “Ultrasound-induced cell membrane porosity,” Ultrasound Med. Biol., vol. 30, pp. 519–526, Apr. 2004.
86. H. Pan, Y. Zhou, O. Izadnegahdar, J. Cui, and C. X. Deng, “Study of sono-poration dynamics affected by ultrasound duty cycle,” Ultrasound Med. Biol., vol. 31, pp. 849–856, June 2005.
87. H. R. Guzman, D. X. Nguyen, S. Khan, and M. R. Prausnitz, “Ultrasound-mediated disruption of cell membranes. II. Heterogeneous effects on cells,” J. Acoust. Soc. Am., vol. 110, pp. 597–606, July 2001.
88. M. Duvshani-Eshet, D. Adam, and M. Machluf, “The effects of albumin-coated microbubbles in DNA delivery mediated by therapeutic ultrasound,” J. Contr. Release, vol. 112, pp. 156–166, May 2006.
89. M. Duvshani-Eshet, L. Baruch, E. Kesselman, E. Shimoni, and M. Machluf, “Therapeutic ultrasound-mediated DNA to cell and nucleus: Bioeffects revealed by confocal and atomic force microscopy,” Gene Ther., vol. 13, pp. 163–172, Jan. 2006.
90. S. Mehier-Humbert, T. Bettinger, F. Yan, and R. H. Guy, “Ultrasound-mediated gene delivery: Kinetics of plasmid internalization and gene expression,” J. Contr. Release, vol. 104, pp. 203–211, May 2005.
91. R. K. Schlicher, H. Radhakrishna, T. P. Tolentino, R. P. Apkarian, V. Zamitsyn, and M. R. Prausnitz, “Mechanism of intracellular delivery by acoustic cavitation,” Ultrasound Med. Biol., vol. 32, pp. 915–924, June 2006.
92. A. van Wamel, K. Kooiman, M. Harteveld, M. Emmer, F. J. ten Cate, M. Versluis, and N. de Jong, “Vibrating microbubbles poking individual cells: Drug transfer into cells via sonoporation,” J. Contr. Release, vol. 112, pp. 149–155, May 2006.
93. C. D. Ohl, M. Arora, R. Ikink, N. de Jong, M. Versluis, M. Delius, and D. Lohse, “Sonoporation from jetting cavitation bubbles,” Biophys. J., vol. 91, pp. 4285–4295, Dec. 2006.
94. E. A. Brujan, “The role of cavitation microjets in the therapeutic applications of ultrasound,” Ultrasound Med. Biol., vol. 30, pp. 381–387, Mar. 2004.
95. E. A. Brujan, T. Ikeda, and Y. Matsumoto, “Jet formation and shock wave emission during collapse of ultrasound-induced cavitation bubbles and their role in the therapeutic applications of high-intensity focused ultrasound,” Phys. Med. Biol., vol. 50, pp. 4797–4809, Oct. 2005.
96. J. Wu, “Theoretical study on shear stress generated by microstreaming surrounding contrast agents attached to living cells,” Ultrasound Med. Biol, vol. 28, pp. 125–129, Jan. 2002.
97. E. C. Unger, T. Porter, W. Culp, R. Labell, T. Matsunaga, and R. Zutshi, “Therapeutic applications of lipid-coated microbubbles,” Adv. Drug Deliv. Rev., vol. 56, pp. 1291–1314, May 2004.
98. P. A. Frenkel, S. Chen, T. Thai, R. V. Shohet, and P. A. Grayburn, “DNA-loaded albumin microbubbles enhance ultrasound-mediated transfection in vitro,” Ultrasound Med Biol., vol. 28, pp. 817–822, June 2002.
99. S. D. Tiukinhoy, M. E. Mahowald, V. P. Shively, A. Nagaraj, B. J. Kane, M. E. Klegerman, R. C. MacDonald, D. D. McPherson, and J. S. Matsumura, “Development of echogenic, plasmid-incorporated, tissue-targeted cationic liposomes that can be used for directed gene delivery,” Invest. Radiol., vol. 35, pp. 732–738, Dec. 2000.
100. J. D. Pruitt and W. G. Pitt, “Sequestration and ultrasound-induced release of doxorubicin from stabilized Pluronic P105 micelles,” Drug Deliv., vol. 9, pp. 253–258, Dec. 2002.
101. J. P. Christiansen, B. A. French, A. L. Klibanov, S. Kaul, and J. R. Lindner, “Targeted tissue transfection with ultrasound destruction of plasmid-bearing cationic microbubbles,” Ultrasound Med. Biol., vol. 29, pp. 1759–1767, Dec. 2003.
102. R. Bekeredjian, S. Chen, P. A. Frenkel, P. A. Grayburn, and R. V. Shohet, “Ultrasound-targeted microbubble destruction can repeatedly direct highly specific plasmid expression to the heart,” Circulation, vol. 108, pp. 1022–1026, Aug. 2003.
103. R. Bekeredjian, S. Chen, P. A. Grayburn, and R. V. Shohet, “Augmentation of cardiac protein delivery using ultrasound targeted microbubble destruction,” Ultrasound Med. Biol., vol. 31, pp. 687–691, May 2005.
104. P. Li, L. Q. Cao, C. Y. Dou, W. F. Armstrong, and D. Miller, “Impact of myocardial contrast echocardiography on vascular permeability: An in vivo dose response study of delivery mode, pressure amplitude and contrast dose,” Ultrasound Med. Biol., vol. 29, pp. 1341–1349, Sept. 2003.
105. R. V. Shohet, S. Chen, Y. T. Zhou, Z. Wang, R. S. Meidell, R. H. Unger, and P. A. Grayburn, “Echocardiographic destruction of albumin microbubbles directs gene delivery to the myocardium,” Circulation, vol. 101, pp. 2554–2556, June 2000.
106. S. Chen, J. Ding, C. Yu, B. Yang, D. R. Wood, and P. A. Grayburn, “Reversal of streptozotocin-induced diabetes in rats by gene therapy with betacellulin and pancreatic duodenal homeobox-1,” Gene Ther., vol. 14, pp. 1102–1110, July 2007.
107. S. Chen, J. H. Ding, R. Bekeredjian, B. Z. Yang, R. V. Shohet, S. A. Johnston, H. E. Hohmeier, C. B. Newgard, and P. A. Grayburn, “Efficient gene delivery to pancreatic islets with ultrasonic microbubble destruction technology,” Proc. Natl. Acad. Sci. USA., vol. 103, pp. 8469–8474, May 2006.
108. G. Korpanty, S. Chen, R. V. Shohet, J. Ding, B. Yang, P. A. Frenkel, and P. A. Grayburn, “Targeting of VEGF-mediated angiogenesis to rat myocardium using ultrasonic destruction of microbubbles,” Gene Ther., vol. 12, pp. 1305–1312, Sept. 2005.
109. M. S. Tartis, J. McCallan, A. F. Lum, R. LaBell, S. M. Stieger, T. O. Matsunaga, and K. W. Ferrara, “Therapeutic effects of paclitaxel-containing ultrasound contrast agents,” Ultrasound Med. Biol., vol. 32, pp. 1771–1780, Nov. 2006.
110. A. F. Lum, M. A. Borden, P. A. Dayton, D. E. Kruse, S. I. Simon, and K. W. Ferrara, “Ultrasound radiation force enables targeted deposition of model drug carriers loaded on microbubbles,” J. Contr. Release, vol. 111, pp. 128–134, Mar. 2006.
111. M. J. Shortencarier, P. A. Dayton, S. H. Bloch, P. A. Schumann, T. O. Matsunaga, and K. W. Ferrara, “A method for radiation-force localized drug delivery using gas-filled lipospheres,” IEEE Trans. Ultrason., Ferroelect., Freq. Contr., vol. 51, pp. 822–831, July 2004.
112. I. Lentacker, B. G. De Geest, R. E. Vandenbroucke, L. Peeters, J. Demeester, S. C. De Smedt, and N. N. Sanders, “Ultrasound-responsive polymer-coated microbubbles that bind and protect DNA,” Langmuir, vol. 22, pp. 7273–7278, Aug. 2006.
113. N. R. Every, L. S. Parsons, M. Hlatky, J. S. Martin, and W. D. Weaver, “A comparison of thrombolytic therapy with primary coronary angioplasty for acute myocardial infarction. Myocardial Infarction Triage and Intervention Investigators,” N. Engl. J. Med., vol. 335, pp. 1253–1260, Oct. 1996.
114. A. M. Lincoff and E. J. Topol, “Illusion of reperfusion. Does anyone achieve optimal reperfusion during acute myocardial infarction?” Circulation, vol. 88, pp. 1361–1374, Sept. 1993.
115. S. Kudo, “Thrombolysis with ultrasound effect,” Tokyo Jikeikai Med. J., vol. 104, pp. 1005–1012, 1989.
116. M. Daffertshofer and M. Fatar, “Therapeutic ultrasound in ischemic stroke treatment: Experimental evidence,” Eur. J. Ultrasound, vol. 16, pp. 121–130, Nov. 2002.
117. C. W. Francis, “Ultrasound-enhanced thrombolysis,” Echocardiography, vol. 18, pp. 239–246, Apr. 2001.
118. J. V. Braaten, R. A. Goss, and C. W. Francis, “Ultrasound reversibly disag-gregates fibrin fibers,” Thromb. Haemostasis, vol. 78, pp. 1063–1068, Sept. 1997.
119. E. C. Everbach and C. W. Francis, “Cavitational mechanisms in ultrasound-accelerated thrombolysis at 1 MHz,” Ultrasound Med. Biol., vol. 26, pp. 1153–1160, Sept. 2000.
120. D. Harpaz, “Ultrasound enhancement of thrombolytic therapy: Observations and mechanisms,” Int. J. Cardiovasc. Interv., vol. 3, pp. 81–89, June 2000.
121. F. Siddiqi, A. Blinc, J. Braaten, and C. W. Francis, “Ultrasound increases flow through fibrin gels,” Thromb. Haemostasis, vol. 73, pp. 495–498, Mar. 1995.
122. S. Datta, C. C. Coussios, L. E. McAdory, J. Tan, T. Porter, G. De Courten-Myers, and C. K. Holland, “Correlation of cavitation with ultrasound enhancement of thrombolysis,” Ultrasound Med. Biol., vol. 32, pp. 1257–1267, Aug. 2006.
123. A. F. Prokop, A. Soltani, and R. A. Roy, “Cavitational mechanisms in ultrasound-accelerated fibrinolysis,” Ultrasound Med. Biol., vol. 33, pp. 924–933, June 2007.
124. J. M. Meunier, C. K. Holland, C. J. Lindsell, and G. J. Shaw, “Duty cycle dependence of ultrasound enhanced thrombolysis in a human clot model,” Ultrasound Med. Biol., vol. 33, pp. 576–583, Apr. 2007.
125. J. F. Polak, “Ultrasound energy and the dissolution of thrombus,” N. Engl. J. Med., vol. 351, pp. 2154–2155, Nov. 2004.
126. S. Schafer, S. Kliner, L. Klinghammer, H. Kaarmann, I. Lucic, U. Nixdorff, U. Rosenschein, W. G. Daniel, and F. A. Flachskampf, “Influence of ultrasound operating parameters on ultrasound-induced thrombolysis in vitro,” Ultrasound Med. Biol., vol. 31, pp. 841–847, June 2005.
127. J. T. Patrick, M. N. Nolting, S. A. Goss, K. A. Dines, J. L. Clendenon, M. A. Rea, and R. F. Heimburger, “Ultrasound and the blood-brain barrier,” Adv. Exp. Med. Biol., vol. 267, pp. 369–381, 1990.
128. N. McDannold, N. Vykhodtseva, and K. Hynynen, “Blood-brain barrier disruption induced by focused ultrasound and circulating preformed microbubbles appears to be characterized by the mechanical index,” Ultrasound Med. Biol., vol. 34, no. 5, pp. 834–840, Jan. 2008.
129. N. McDannold, N. Vykhodtseva, and K. Hynynen, “Effects of acoustic parameters and ultrasound contrast agent dose on focused-ultrasound induced blood-brain barrier disruption,” Ultrasound Med. Biol., vol. 34, pp. 930–937, Feb. 2008.
130. F. Y. Yang, W. M. Fu, W. S. Chen, W. L. Yeh, and W. L. Lin, “Quantitative evaluation of the use of microbubbles with transcranial focused ultrasound on blood-brain-barrier disruption,” Ultrason. Sonochem., vol. 15, pp. 636–643, Apr. 2008.
131. M. Kinoshita, N. McDannold, F. A. Jolesz, and K. Hynynen, “Targeted delivery of antibodies through the blood-brain barrier by MRI-guided focused ultrasound,” Biochem. Biophys. Res. Commun., vol. 340, pp. 1085–1090, Feb. 2006.
132. L. H. Treat, N. McDannold, N. Vykhodtseva, Y. Zhang, K. Tam, and K. Hynynen, “Targeted delivery of doxorubicin to the rat brain at therapeutic levels using MRI-guided focused ultrasound,” Int. J. Cancer, vol. 121, pp. 901–907, Aug. 2007.
133. S. Meairs and A. Alonso, “Ultrasound, microbubbles and the blood-brain barrier,” Prog. Biophys. Mol. Biol., vol. 93, pp. 354–362, Apr. 2007.
134. K. Hynynen, “Ultrasound for drug and gene delivery to the brain,” Adv. Drug Deliv. Rev., vol. 60, pp. 1209–1217, June 2008.
135. S. Dromi, V. Frenkel, A. Luk, B. Traughber, M. Angstadt, M. Bur, J. Poff, J. Xie, S. K. Libutti, K. C. Li, and B. J. Wood, “Pulsed-high intensity focused ultrasound and low temperature-sensitive liposomes for enhanced targeted drug delivery and antitumor effect,” Clin. Cancer Res., vol. 13, pp. 2722–2727, May 2007.
136. R. C. Smith, M. Machluf, P. Bromley, A. Atala, and K. Walsh, “Spatial and temporal control of transgene expression through ultrasound-mediated induction of the heat shock protein 70B promoter in vivo,” Hum. Gene Ther., vol. 13, pp. 697–706, Apr. 2002.
137. Y. Liu, T. Kon, C. Li, and P. Zhong, “High intensity focused ultrasound-induced gene activation in sublethally injured tumor cells in vitro,” J. Acoust. Soc. Am., vol. 118, pp. 3328–3336, Nov. 2005.
138. Y. Liu, T. Kon, C. Li, and P. Zhong, “High intensity focused ultrasound-induced gene activation in solid tumors,” J. Acoust. Soc. Am., vol. 120, pp. 492–501, July 2006.
139. G. Sankin, F. Yuan, and P. Zhong, “Damage to single biological cells induced by laser-induced tandem microbubbles,” presented at the Acoustics '08, Paris, France, 2008.
140. E. C. Unger, E. Hersh, M. Vannan, T. O. Matsunaga, and T. McCreery, “Local drug and gene delivery through microbubbles,” Prog. Cardiovasc. Diseases, vol. 44, pp. 45–54, Aug. 2001.
141. K. Tachibana, T. Uchida, K. Ogawa, N. Yamashita, and K. Tamura, “Induction of cell-membrane porosity by ultrasound,” Lancet, vol. 353, p. 1409, Apr. 1999.